Questions About Bone Drugs Persist Despite Media Hype

Questions About Bone Drugs Persist Despite Media Hype
Ajale
Martha Rosenberg
Updated:

There is an old saying that if you keep going into a barber shop, eventually you will get a haircut. The same can be said of Pharma’s many health “screenings.”

The suggestions to get screenings for depression, “osteopenia” or even exocrine pancreatic insufficiency (EPI) are meant to sound like they come from public health programs. Some are even given public service announcement status, running on media for free. But they are what is now called “disease mongering”––selling a disease and the fear of the disease to find new patients to take expensive drugs. The ad industry calls them “unbranded” advertising because they never mention the drug they are pushing––just the disease they want you to fear. So you'll get the haircut.

Martha Rosenberg
Martha Rosenberg
Author
Martha Rosenberg is a nationally recognized reporter and author whose work has been cited by the Mayo Clinic Proceedings, Public Library of Science Biology, and National Geographic. Rosenberg’s FDA expose, "Born with a Junk Food Deficiency," established her as a prominent investigative journalist. She has lectured widely at universities throughout the United States and resides in Chicago.
facebook
Related Topics